News

Big gains in type 1 diabetes glucose-control management in recent years

A new study led by researchers at the Johns Hopkins Bloomberg School of Public Health reveals significant improvements in blood sugar management among individuals with type 1 diabetes over the past 15 years, driven by the widespread adoption of continuous glucose monitoring (CGM) and insulin delivery devices.

The study analyzed nearly 200,000 de-identified electronic health records from 2009 to 2023, tracking the use of CGM and insulin pumps alongside blood sugar control (measured by HbA1c levels). Key findings include:

  • Improved Glucose Control: The percentage of children under 18 with optimal HbA1c levels (<7%) rose from 7% (2009–2011) to 19% (2021–2023)—a 171% increase. Among adults, optimal control increased from 21% to 28% (33% increase).
  • Surge in Technology Use:
    • CGM adoption skyrocketed from 4% to 82% in youths and 5% to 57% in adults.
    • Insulin pump use rose from 16% to 50% in youths and 11% to 29% in adults.
    • Concurrent use of both devices jumped from 1% to 47% in youths and 1% to 22% in adults.

Despite progress, disparities persist, with non-Hispanic white patients and those with commercial insurance showing higher rates of technology adoption and glucose control. For example, only 12% of non-Hispanic Black youths achieved optimal control in 2021–2023, compared to 21% of non-Hispanic white youths.

The researchers emphasize the need for better access to diabetes technologies to reduce these gaps. While the advancements are promising, most patients still do not meet optimal glucose targets, indicating room for further improvement.

Published in JAMA Network Open (August 11), the study highlights how modern diabetes technologies have transformed care, with future research planned to examine long-term complications like heart and kidney disease in type 1 diabetes patients.


Key Takeaways:

  1. Technology Drives Improvement: CGM and insulin pumps have significantly enhanced blood sugar management.
  2. Disparities Remain: Racial and insurance-based gaps in access and outcomes need addressing.
  3. Ongoing Challenges: Most patients still lack optimal control, calling for further innovation and policy changes.

Understanding a ‘Diabetic Foot Attack’

Diabetic foot attack represents one of the most serious and potentially life-threatening complications of diabetes mellitus, affecting millions of people worldwide. This acute medical emergency occurs when diabetes-related complications converge to create a cascade of tissue damage, infection, and vascular compromise in the foot and lower extremity. Understanding the nature, causes, and management of diabetic foot attacks is crucial for healthcare providers, patients, and caregivers alike, as early recognition and intervention can mean the difference between limb preservation and amputation.

Defining Diabetic Foot Attack

A diabetic foot attack is characterized by the rapid deterioration of foot health in diabetic patients, typically involving severe infection, tissue necrosis, and systemic complications that require immediate medical intervention. Unlike chronic diabetic foot problems that develop gradually over time, a diabetic foot attack represents an acute exacerbation where multiple pathological processes accelerate simultaneously, creating a medical emergency. The term encompasses scenarios where patients experience sudden onset of severe foot pain, rapidly spreading infection, tissue death, or systemic signs of sepsis originating from foot complications.

The concept parallels other medical emergencies like heart attacks or strokes, emphasizing the urgent nature of the condition and the need for rapid, coordinated medical response. Just as a heart attack involves acute interruption of blood flow to cardiac muscle, a diabetic foot attack involves acute compromise of tissue viability in the diabetic foot, often with systemic implications that can be life-threatening if not promptly addressed.

Underlying Pathophysiology

The pathophysiology of diabetic foot attacks stems from three primary diabetic complications working in concert: peripheral neuropathy, peripheral arterial disease, and impaired immune function. Peripheral neuropathy, affecting up to 50% of diabetic patients, results in loss of protective sensation, making patients unaware of minor injuries, pressure points, or developing infections. This sensory loss, combined with motor neuropathy that leads to foot deformities and abnormal pressure distribution, creates an environment where tissue damage can occur unnoticed.

Peripheral arterial disease, present in approximately 20-30% of diabetic patients, compromises blood flow to the extremities, impairing wound healing and tissue oxygenation. When combined with the metabolic effects of hyperglycemia, which impairs white blood cell function and creates an environment favorable to bacterial growth, even minor injuries can rapidly progress to serious infections.

During a diabetic foot attack, these underlying conditions create a perfect storm. A small wound or ulcer becomes rapidly infected, with bacteria spreading through tissue planes compromised by poor circulation. The infection can progress from superficial skin involvement to deep tissue, bone, and even systemic sepsis within hours to days. The poor healing capacity of diabetic tissue means that the body’s natural defense mechanisms are overwhelmed, allowing the infectious process to advance unchecked.

Clinical Presentation and Recognition

Recognizing a diabetic foot attack requires understanding its varied presentations. Patients may present with acute onset of severe foot pain, though ironically, those with advanced neuropathy may experience minimal pain despite severe tissue damage. More reliable indicators include rapid onset of foot swelling, erythema extending beyond the immediate wound area, purulent discharge with foul odor, and systemic signs such as fever, chills, or altered mental status.

The affected foot may show signs of cellulitis with red streaking, indicating lymphangitis, or areas of tissue necrosis appearing as black or dark brown discoloration. In severe cases, gas gangrene may develop, characterized by crepitus on examination and rapid tissue destruction. Patients may also present with diabetic ketoacidosis triggered by the severe infection, representing a dual emergency requiring simultaneous management.

Laboratory findings typically reveal elevated white blood cell count, increased inflammatory markers like C-reactive protein and erythrocyte sedimentation rate, and often significantly elevated blood glucose levels. Blood cultures may be positive, indicating bacteremia, while imaging studies might reveal gas in tissues, osteomyelitis, or abscess formation.

Management and Treatment Strategies

The management of diabetic foot attacks requires immediate, aggressive intervention across multiple fronts. Emergency department triage should prioritize these patients, as delays in treatment directly correlate with worse outcomes, including higher amputation rates and mortality. Initial assessment must include rapid evaluation of hemodynamic stability, blood glucose control, and the extent of local and systemic infection.

Immediate interventions include broad-spectrum intravenous antibiotics, aggressive surgical debridement of necrotic tissue, drainage of abscesses, and in severe cases, emergency amputation to prevent further spread of infection. Blood glucose control is crucial, often requiring insulin infusions to rapidly normalize glucose levels and optimize immune function. Fluid resuscitation and supportive care address systemic effects of sepsis.

The multidisciplinary approach is essential, involving emergency physicians, endocrinologists, infectious disease specialists, vascular surgeons, orthopedic surgeons, and wound care specialists. Vascular assessment may reveal the need for emergency revascularization procedures to improve blood flow to the affected area. Hyperbaric oxygen therapy may be considered as an adjunctive treatment in selected cases to enhance tissue oxygenation and healing.

Prevention and Long-term Implications

Prevention remains the most effective strategy against diabetic foot attacks. This involves comprehensive diabetes management with optimal glycemic control, regular foot examinations by healthcare providers, daily patient self-inspection of feet, appropriate footwear, and prompt attention to any foot injuries or changes. Patient education about proper foot care, recognition of warning signs, and the importance of seeking immediate medical attention for foot problems is crucial.

The long-term implications of diabetic foot attacks extend beyond the immediate medical emergency. Survivors face increased risk of future episodes, potential disability from amputation, psychological impact from the traumatic experience, and substantially increased healthcare costs. The mortality rate associated with diabetic foot attacks, particularly when complicated by sepsis, remains significant, with studies showing increased mortality risk that persists for years following the acute episode.

Bunions in Individuals with Diabetes

Bunions are a common foot complication that can affect anyone, but individuals with diabetes are particularly susceptible to developing bunions due to a combination of factors. Bunions can cause discomfort, pain, and mobility issues, which can significantly impact the quality of life for individuals with diabetes.

What are Bunions?

A bunion is a bony bump that forms on the joint at the base of the big toe. It occurs when the toe is forced out of its normal position, causing the joint to become misaligned. Bunions can be caused by a variety of factors, including genetics, poorly fitting shoes, and abnormal gait.

Why are Individuals with Diabetes at Risk for Bunions?

Individuals with diabetes are at increased risk for developing bunions due to several factors, including [1]:

  • Neuropathy: Diabetic neuropathy can cause numbness and loss of sensation in the feet, making it difficult to detect pain or discomfort associated with bunions.
  • Poor circulation: Poor circulation, which is common in diabetes, can impede healing and increase the risk of complications from bunions.
  • Foot deformities: Diabetes can cause foot deformities, such as hammertoes or Charcot foot, which can increase the risk of bunions.
  • Obesity: Obesity, which is often associated with type 2 diabetes, can put additional stress on the feet and increase the risk of bunions.

Symptoms and Complications of Bunions in Diabetes

Bunions can cause a range of symptoms, including pain, redness, and swelling. In individuals with diabetes, bunions can lead to more serious complications, such as [2]:

  • Ulceration: Bunions can cause pressure points on the skin, which can lead to ulceration and infection.
  • Infection: Infections can spread quickly in individuals with diabetes, particularly if they have poor circulation or neuropathy.
  • Mobility issues: Bunions can cause pain and discomfort, which can limit mobility and increase the risk of falls.

Treatment and Management of Bunions in Diabetes

Treatment and management of bunions in individuals with diabetes require a comprehensive approach that includes [3]:

  • Proper footwear: Wearing shoes that fit properly and provide adequate support can help reduce pressure on the bunion.
  • Orthotics: Custom orthotics can help redistribute pressure and alleviate pain.
  • Pain management: Pain management medications, such as acetaminophen or NSAIDs, can help reduce pain and discomfort.
  • Surgical intervention: In some cases, surgical intervention may be necessary to correct the bunion and alleviate symptoms.

Prevention

Preventing bunions in individuals with diabetes requires a proactive approach that includes:

  • Regular foot exams: Regular foot exams can help identify bunions early, when they are easier to treat.
  • Proper footwear: Wearing shoes that fit properly and provide adequate support can help reduce the risk of bunions.
  • Weight management: Maintaining a healthy weight can reduce the stress on the feet and lower the risk of bunions.

Bunions are a common foot complication that can affect individuals with diabetes. Understanding the causes, symptoms, and complications of bunions can help healthcare providers develop effective treatment and management plans. By working together, healthcare providers and individuals with diabetes can reduce the risk of bunions and related complications, and improve overall foot health.

References

  1. Boulton AJM, et al. (2018). The global burden of diabetic foot disease. The Lancet, 392(10151), 844-854.
  2. Armstrong DG, et al. (2017). Diabetic foot ulcers: A review of the evidence. Journal of Clinical and Translational Research, 3(2), 54-64.
  3. Bus SA, et al. (2016). IWGDF guidance on the prevention of foot ulcers in persons with diabetes. Diabetes/Metabolism Research and Reviews, 32(Suppl 1), 84-93.

Atrial Fibrillation in Diabetes: A Growing Concern

Atrial fibrillation (AF) is a common cardiac arrhythmia that affects millions of people worldwide. Individuals with diabetes are at increased risk of developing AF, and the presence of AF can significantly impact the management of diabetes and overall health outcomes.

The Link Between Diabetes and Atrial Fibrillation

The link between diabetes and atrial fibrillation is complex and multifactorial. Several mechanisms contribute to the increased risk of AF in individuals with diabetes, including [1]:

  • Inflammation: Chronic inflammation, often seen in diabetes, can contribute to the development of AF.
  • Oxidative stress: Oxidative stress, which is increased in diabetes, can damage the heart and contribute to the development of AF.
  • Cardiac remodeling: Diabetes can lead to cardiac remodeling, including changes in the structure and function of the heart, which can increase the risk of AF.

Risk Factors for Atrial Fibrillation in Diabetes

Several risk factors contribute to the development of atrial fibrillation in individuals with diabetes, including [2]:

  • Age: Older adults with diabetes are at increased risk of AF.
  • Hypertension: Hypertension, which is common in diabetes, can increase the risk of AF.
  • Obesity: Obesity, which is often seen in type 2 diabetes, can increase the risk of AF.
  • Kidney disease: Kidney disease, which is a common complication of diabetes, can increase the risk of AF.

Management of Atrial Fibrillation in Diabetes

The management of atrial fibrillation in individuals with diabetes requires a comprehensive approach that includes [3]:

  • Rate control: Rate control medications, such as beta blockers or calcium channel blockers, can help control heart rate and reduce symptoms.
  • Rhythm control: Rhythm control medications, such as anti-arrhythmic medications, can help restore a normal heart rhythm.
  • Anticoagulation: Anticoagulation therapy, such as warfarin or direct oral anticoagulants, can help reduce the risk of stroke and systemic embolism.
  • Lifestyle modifications: Lifestyle modifications, such as weight loss, exercise, and stress reduction, can help manage AF and reduce the risk of complications.

Importance of Early Detection and Treatment

Early detection and treatment of atrial fibrillation in individuals with diabetes are critical to preventing complications and improving outcomes. Regular monitoring for AF, particularly in high-risk individuals, can help identify AF early, and prompt treatment can help reduce the risk of stroke and other complications.

Atrial fibrillation is a common and significant complication of diabetes. Understanding the link between diabetes and AF, and identifying risk factors, can help healthcare providers develop effective management plans and improve outcomes for individuals with diabetes. By working together, healthcare providers and individuals with diabetes can reduce the risk of AF and its complications, and improve overall health outcomes.

References

  1. Lip GYH, et al. (2018). Atrial fibrillation in diabetes: A review of the evidence. Diabetes, Obesity and Metabolism, 20(3), 545-555.
  2. Du X, et al. (2018). Diabetes and risk of atrial fibrillation: A systematic review and meta-analysis. International Journal of Cardiology, 253, 128-134.
  3. January CT, et al. (2019). 2019 AHA/ACC/HRS focused update of the guideline for the management of patients with atrial fibrillation. Circulation, 140(10), e583-e594.

Association Between Physical Activity and Mortality and Cardiovascular Events in People with Type 2 Diabetes

A recent study presented at the European Association for the Study of Diabetes (EASD) Annual Meeting in Vienna, Austria, has found a clear association between physical activity and the risk of all-cause mortality and major adverse cardiac events (MACE) in people recently diagnosed with type 2 diabetes and no previous cardiovascular disease. The study, which analyzed data from over 11,000 participants, found that higher levels of physical activity were associated with a lower risk of MACE and all-cause mortality.

The Study’s Findings

The study categorized participants into three groups based on their self-reported physical activity: sedentary, light physical activity, and moderate-to-vigorous physical activity (MVPA). The results showed that participants who engaged in light physical activity and MVPA had a 23% and 28% lower risk of MACE, respectively, compared to sedentary participants. Additionally, light physical activity and MVPA were associated with a 27% and 33% lower risk of all-cause mortality, respectively.

The Importance of Physical Activity

The study’s findings highlight the importance of physical activity for people with type 2 diabetes. Even light physical activity was found to reduce the risk of serious cardiac events and all-cause mortality, independently of classical cardiovascular disease risk factors. This suggests that incorporating physical activity into one’s lifestyle can have significant health benefits, even for those who may not be able to engage in high-intensity exercise.

Implications for Public Health

The study’s findings have important implications for public health. They suggest that promoting physical activity among people with type 2 diabetes can help to reduce the risk of cardiovascular disease and premature mortality. Healthcare providers can use these findings to counsel patients on the importance of physical activity and encourage them to incorporate it into their lifestyle.

In conclusion, the study provides evidence that physical activity is an independent predictor of all-cause mortality and MACE in people recently diagnosed with type 2 diabetes and no previous cardiovascular disease. The findings highlight the importance of promoting physical activity among people with type 2 diabetes and suggest that even light physical activity can have significant health benefits. By incorporating physical activity into their lifestyle, people with type 2 diabetes can reduce their risk of cardiovascular disease and premature mortality.

Three weekly servings of French fries linked to higher diabetes risk

A recent study published in The BMJ found that eating three servings of French fries per week is associated with a 20% increased risk of developing type 2 diabetes. However, consuming similar amounts of boiled, baked, or mashed potatoes does not substantially increase the risk. The study, which followed over 205,000 health professionals for almost 40 years, also found that replacing potatoes with whole grains can lower the risk of type 2 diabetes, while replacing them with white rice can increase the risk. The researchers emphasize the importance of considering preparation method and replacement food when evaluating the health impact of potatoes.

The Importance of Preparation Method

The study highlights the importance of considering the preparation method of potatoes when evaluating their health impact. French fries, which are typically high in fat and calories, may be particularly detrimental to health due to their high glycemic index and potential to contribute to weight gain and insulin resistance. In contrast, boiled, baked, or mashed potatoes, which are lower in fat and calories, do not appear to increase the risk of type 2 diabetes to the same extent.

Replacing Potatoes with Whole Grains

The study also found that replacing potatoes with whole grains can lower the risk of type 2 diabetes. For every three servings of potatoes replaced with whole grains, the risk of type 2 diabetes decreased by 8%. This finding is consistent with current dietary recommendations that promote the inclusion of whole grains as part of a healthy diet for the prevention of type 2 diabetes.

Implications for Public Health

The study’s findings have important implications for public health. They suggest that people who consume large amounts of French fries may be at increased risk of developing type 2 diabetes, and that replacing French fries with whole grains or other healthier options may help to mitigate this risk. Additionally, the study highlights the importance of considering the preparation method of potatoes when evaluating their health impact, and suggests that baked, boiled, or mashed potatoes can be part of a healthy and sustainable diet.

Limitations of the Study

While the study’s findings are significant, there are some limitations to consider. The study was observational, meaning that it cannot establish cause-and-effect relationships between potato consumption and type 2 diabetes risk. Additionally, the study population was primarily composed of health professionals of European ancestry, which may limit the generalizability of the findings to other populations.

In conclusion, the study provides evidence that consuming large amounts of French fries is associated with an increased risk of type 2 diabetes, while consuming boiled, baked, or mashed potatoes does not substantially increase the risk. Replacing potatoes with whole grains can lower the risk of type 2 diabetes, and baked, boiled, or mashed potatoes can be part of a healthy and sustainable diet. These findings have important implications for public health and highlight the importance of considering the preparation method of potatoes when evaluating their health impact.

Should People with Diabetes Wear Flip Flops?

When it comes to footwear, people with diabetes need to be particularly cautious. Diabetes can cause nerve damage, known as neuropathy, which can lead to a loss of sensation in the feet. This makes it more difficult for individuals to detect injuries or irritations, increasing the risk of complications like foot ulcers and infections. Given these risks, the question arises: should people with diabetes wear flip flops?

Risks Associated with Flip Flops

Flip flops are a popular choice for warm weather due to their comfort and ease (eg Archies). However, they offer little to no protection for the feet. For people with diabetes, this lack of protection can pose significant risks:

  1. Increased risk of injury: Flip flops provide minimal coverage, leaving the feet vulnerable to cuts, scrapes, and other injuries. For someone with diabetes, even a small cut can become a serious issue if not properly cared for.
  2. Exposure to foreign objects: Flip flops do not protect the feet from sharp objects, hot surfaces, or other hazards that could cause injury.
  3. Poor foot support: Flip flops often lack the arch support and stability that people with diabetes need to prevent foot problems like plantar fasciitis or other structural issues.
  4. Increased risk of infection: If an injury occurs while wearing flip flops, the risk of infection is higher due to the open nature of the footwear.

Considerations for People with Diabetes

Given the potential risks, it’s essential for people with diabetes to carefully consider their footwear choices. While flip flops might be comfortable and convenient, they may not be the best option for everyday wear, especially in situations where the feet are more prone to injury.

Alternatives to Flip Flops

For people with diabetes, it’s often recommended to opt for shoes that provide better protection and support. Some alternatives to flip flops include:

  1. Closed-toe shoes: Shoes that cover the entire foot can protect against injuries and provide better support.
  2. Orthotic shoes: Custom orthotics or shoes designed for people with diabetes can offer additional support and protection.
  3. Therapeutic footwear: Specialized footwear designed for people with diabetes can help prevent foot complications and promote healing.

While flip flops might be a comfortable choice for some, people with diabetes should approach wearing them with caution. The risks associated with flip flops, such as increased vulnerability to injury and infection, make them a less-than-ideal choice for everyday wear. Instead, individuals with diabetes should prioritize footwear that offers protection, support, and comfort to help prevent complications and maintain foot health. Consulting with a healthcare provider or podiatrist can provide personalized guidance on the best footwear options for managing diabetes-related foot issues.

DASH Diet Modified for Diabetes Lowers Blood Sugar Levels in Clinical Trial

A recent clinical trial led by researchers at Johns Hopkins Bloomberg School of Public Health found that a modified version of the DASH diet, called DASH4D, is effective in lowering blood sugar levels in adults with type 2 diabetes. The DASH4D diet is similar to the original DASH diet but is lower in carbohydrates and higher in unsaturated fats, with reduced potassium levels to improve safety for individuals with chronic kidney disease.

The study, published in Nature Medicine, involved 89 participants with type 2 diabetes who ate prepared meals at a clinical research center for 20 weeks. The results showed that when participants consumed the DASH4D diet, they had a clinically meaningful reduction in average blood glucose level and an increase in average time spent with blood glucose in the recommended range compared to when they consumed a standard diet.

Specifically, the study found that:

  • Participants on the DASH4D diet had blood sugar levels that were on average 11 mg/dL lower than when eating the standard diet.
  • Participants on the DASH4D diet stayed in the optimal blood glucose range for an extra 75 minutes a day.
  • Larger improvements were seen in participants who had higher blood glucose levels at the start of the trial, with those with HbA1c above 8% experiencing an increase in time in the optimal blood glucose range by about three hours per day.

The researchers hope that the results will lead to incorporating the DASH4D diet into clinical guidelines and improving type 2 diabetes management in the broader population. The study’s findings suggest that the DASH4D diet can be a sustainable and effective approach to managing type 2 diabetes, with potential benefits for population health.

Skin Care of the Foot in Those with Diabetes

Diabetes is a chronic condition that can have a significant impact on the health of the feet. Individuals with diabetes are at increased risk of developing foot complications, including ulcers, infections, and amputations. Proper skin care of the foot is essential for preventing these complications and maintaining overall foot health.

Continue reading “Skin Care of the Foot in Those with Diabetes”

Phase 3 study supports use of canagliflozin for type 2 diabetes in children and adolescents

A recent phase 3 clinical trial published in Annals of Internal Medicine supports the use of canagliflozin for treating type 2 diabetes in children and adolescents. The study involved 171 participants aged 10-18 years with inadequate glycemic control, who received either oral canagliflozin or a placebo for 52 weeks.

Continue reading “Phase 3 study supports use of canagliflozin for type 2 diabetes in children and adolescents”

Latest Cures for Chilblains in Diabetes

Chilblains, also known as perniosis, are a common condition characterized by inflammation of small blood vessels in response to cold temperatures. People with diabetes are particularly susceptible to chilblains due to impaired blood circulation and neuropathy. Effective treatment of chilblains in individuals with diabetes requires a comprehensive approach that addresses both the symptoms and underlying causes.

Continue reading “Latest Cures for Chilblains in Diabetes”